RedHill Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	8.04	6.53	61.8	85.76	64.36	Upgrade
Revenue	8.04	6.53	61.8	85.76	64.36	Upgrade
Revenue Growth (YoY)	23.17%	-89.43%	-27.94%	33.25%	923.03%	Upgrade
Cost of Revenue	3.19	3.46	33.34	49.41	36.89	Upgrade
Gross Profit	4.85	3.07	28.46	36.35	27.47	Upgrade
Selling, General & Admin	15.52	30.98	64.03	87.99	74.66	Upgrade
Research & Development	1.59	3.53	7.28	29.5	16.49	Upgrade
Other Operating Expenses	-	-8.56	-	-	-	Upgrade
Operating Expenses	17.11	25.94	71.31	117.49	91.15	Upgrade
Operating Income	-12.25	-22.87	-42.84	-81.14	-63.68	Upgrade
Interest Expense	-0.06	-0.37	-41.33	-16.57	-12.45	Upgrade
Interest & Investment Income	0.13	0.09	0.14	0.05	0.18	Upgrade
Currency Exchange Gain (Loss)	-0.03	-0.12	-0.04	-0.03	-0.01	Upgrade
Other Non Operating Income (Expenses)	6.3	-7.45	12.41	-0.07	-0.3	Upgrade
EBT Excluding Unusual Items	-5.91	-30.71	-71.67	-97.74	-76.27	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	0.09	Upgrade
Gain (Loss) on Sale of Assets	-	35.5	-	-	-	Upgrade
Other Unusual Items	-2.36	19.13	-	-	-	Upgrade
Pretax Income	-8.27	23.92	-71.67	-97.74	-76.17	Upgrade
Net Income	-8.27	23.92	-71.67	-97.74	-76.17	Upgrade
Net Income to Common	-8.27	23.92	-71.67	-97.74	-76.17	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	Upgrade
Shares Change (YoY)	375.56%	320.45%	32.46%	27.72%	22.69%	Upgrade
EPS (Basic)	-6.71	92.30	-1162.89	-2100.80	-2091.06	Upgrade
EPS (Diluted)	-6.71	92.30	-1162.89	-2100.80	-2091.06	Upgrade
Free Cash Flow	-9.38	-35.83	-29.38	-65.16	-48.99	Upgrade
Free Cash Flow Per Share	-7.61	-138.28	-476.76	-1400.52	-1344.71	Upgrade
Gross Margin	60.31%	47.03%	46.06%	42.39%	42.68%	Upgrade
Operating Margin	-152.36%	-350.20%	-69.33%	-94.61%	-98.95%	Upgrade
Profit Margin	-102.80%	366.25%	-115.97%	-113.98%	-118.36%	Upgrade
Free Cash Flow Margin	-116.60%	-548.71%	-47.55%	-75.98%	-76.11%	Upgrade
EBITDA	-12.16	-22.15	-34.69	-62.99	-54.94	Upgrade
EBITDA Margin	-151.14%	-	-56.13%	-73.45%	-85.36%	Upgrade
D&A For EBITDA	0.1	0.71	8.15	18.15	8.75	Upgrade
EBIT	-12.25	-22.87	-42.84	-81.14	-63.68	Upgrade
EBIT Margin	-152.36%	-	-69.33%	-94.61%	-98.95%	Upgrade

Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q